1 year return (CAGR)
-
Avalyn Pharma Inc. Common Stock Exchange (NASDAQ, USD)
AVLN
33.43
+0.43 (+1.25%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.54B
Price/Sales
-
Ent value
1.30B
Price/Book
3.86
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 34.38 |
| Daily high | 35.20 |
| Daily low | 34.09 |
| Daily Volume | 244K |
| All-time high | 39.25 |
| 1y analyst estimate | 62.25 |
| Beta | - |
| EPS (TTM) | -1.65 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| AVLN | S&P500 | |
| Current price drop from All-time high | -14.83% | -1.96% |
| Highest price drop | -22.11% | -56.47% |
| Date of highest drop | 16 Jul 2026 | 9 Mar 2009 |
| Avg drop from high | -8.13% | -10.68% |
| Avg time to new high | 9 days | 12 days |
| Max time to new high | 33 days | 1805 days |
News
